JP2010106028A5 - - Google Patents

Download PDF

Info

Publication number
JP2010106028A5
JP2010106028A5 JP2009271611A JP2009271611A JP2010106028A5 JP 2010106028 A5 JP2010106028 A5 JP 2010106028A5 JP 2009271611 A JP2009271611 A JP 2009271611A JP 2009271611 A JP2009271611 A JP 2009271611A JP 2010106028 A5 JP2010106028 A5 JP 2010106028A5
Authority
JP
Japan
Prior art keywords
cancer
cell surface
kit
binding region
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009271611A
Other languages
English (en)
Japanese (ja)
Other versions
JP5926474B2 (ja
JP2010106028A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010106028A publication Critical patent/JP2010106028A/ja
Publication of JP2010106028A5 publication Critical patent/JP2010106028A5/ja
Application granted granted Critical
Publication of JP5926474B2 publication Critical patent/JP5926474B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009271611A 2000-11-27 2009-11-30 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法 Expired - Lifetime JP5926474B2 (ja)

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US25336100P 2000-11-27 2000-11-27
US60/253,361 2000-11-27
US25537000P 2000-12-13 2000-12-13
US60/255,370 2000-12-13
US25602700P 2000-12-15 2000-12-15
US60/256,027 2000-12-15
US25815700P 2000-12-22 2000-12-22
US60/258,157 2000-12-22
US25961501P 2001-01-03 2001-01-03
US60/259,615 2001-01-03
US26018601P 2001-01-05 2001-01-05
US60/260,186 2001-01-05
US26616901P 2001-02-02 2001-02-02
US60/266,169 2001-02-02
US26692901P 2001-02-06 2001-02-06
US60/266,929 2001-02-06
US27809301P 2001-03-23 2001-03-23
US60/278,093 2001-03-23
US28944401P 2001-05-07 2001-05-07
US60/289,444 2001-05-07
US29488701P 2001-05-31 2001-05-31
US60/294,887 2001-05-31
US29827201P 2001-06-14 2001-06-14
US60/298,272 2001-06-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002556226A Division JP4564714B2 (ja) 2000-11-27 2001-11-27 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014205598A Division JP6124856B2 (ja) 2000-11-27 2014-10-06 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法

Publications (3)

Publication Number Publication Date
JP2010106028A JP2010106028A (ja) 2010-05-13
JP2010106028A5 true JP2010106028A5 (zh) 2011-03-03
JP5926474B2 JP5926474B2 (ja) 2016-05-25

Family

ID=27583824

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2002556226A Expired - Lifetime JP4564714B2 (ja) 2000-11-27 2001-11-27 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法
JP2009271611A Expired - Lifetime JP5926474B2 (ja) 2000-11-27 2009-11-30 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法
JP2014205598A Expired - Lifetime JP6124856B2 (ja) 2000-11-27 2014-10-06 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法
JP2017013054A Expired - Lifetime JP6516778B2 (ja) 2000-11-27 2017-01-27 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002556226A Expired - Lifetime JP4564714B2 (ja) 2000-11-27 2001-11-27 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014205598A Expired - Lifetime JP6124856B2 (ja) 2000-11-27 2014-10-06 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法
JP2017013054A Expired - Lifetime JP6516778B2 (ja) 2000-11-27 2017-01-27 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法

Country Status (7)

Country Link
US (3) US7700715B2 (zh)
EP (4) EP1354196B1 (zh)
JP (4) JP4564714B2 (zh)
AT (1) ATE481640T1 (zh)
CA (1) CA2430060C (zh)
DK (1) DK2322929T3 (zh)
WO (1) WO2002056022A2 (zh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148101A1 (en) * 1999-01-23 2005-07-07 Bamdad Cynthia C. Interaction of colloid-immobilized species with species on non-colloidal structures
WO2002028507A2 (en) 2000-10-03 2002-04-11 Minerva Biotechnologies Corporation Electronic detection of interaction based on the interruption of flow
EP1354196B1 (en) * 2000-11-27 2010-09-15 Minerva Biotechnologies Corporation Diagnostics, drug screening and treatment for cancer
AU2002252459A1 (en) * 2001-03-22 2002-10-08 Minerva Biotechnologies Corporation Customized therapeutics and in situ diagnostics
WO2003020279A2 (en) 2001-09-05 2003-03-13 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
US20060280730A1 (en) * 2001-10-12 2006-12-14 Cedars-Sinai Medical Center Induction of apoptosis of malignant cells by activation of calcium-activated potassium channels
US7211561B2 (en) * 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
US20090118605A1 (en) * 2002-08-30 2009-05-07 Northwestern University Surface-enhanced raman nanobiosensor
US20040180379A1 (en) * 2002-08-30 2004-09-16 Northwestern University Surface-enhanced raman nanobiosensor
US7528168B2 (en) 2002-09-19 2009-05-05 John Nieland Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases
JP2007531505A (ja) * 2002-11-27 2007-11-08 ミネルバ バイオオテクノロジーズ コーポレーション 癌（ｍｕｃ１）の診断および治療のための技術および組成物
WO2004071458A2 (en) * 2003-02-13 2004-08-26 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
EP1625387A4 (en) * 2003-05-13 2007-08-08 Minerva Biotechnologies Corp STORAGE AND USE OF COLLOIDS
EP1651207A4 (en) 2003-06-12 2008-10-01 Univ Colorado SYSTEMS AND METHOD FOR THE TREATMENT OF INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS OF HUMANS WITH FATTY ACID SUBSTANCE CHEMICALS AND / OR GLYCOLYTIC INHIBITORS
US20060173171A1 (en) * 2003-08-26 2006-08-03 Bamdad Cynthia C Techniques and compositions for diagnosis and treatment of cancer (muci)
DK2363410T3 (en) * 2003-08-26 2018-01-15 Minerva Biotechnologies Corp ISOFORMER OF MUC1
ES2629682T3 (es) 2004-03-29 2017-08-14 University Of South Florida Tratamiento efectivo de tumores y cáncer con fosfato de triciribina
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100173864A1 (en) * 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20080064680A1 (en) * 2004-09-14 2008-03-13 Bamdad Cynthia C Methods for Diagnosis and Treatment of Cancer
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
CA2595778A1 (en) * 2005-01-28 2006-08-03 Ramot At Tel Aviv University, Ltd. Anti-muc1 .alpha..beta. antibodies
WO2006088875A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels
JP2008543276A (ja) * 2005-03-30 2008-12-04 ミネルバ バイオテクノロジーズ コーポレーション Ｍｕｃ１発現細胞の増殖
ES2720288T3 (es) 2005-03-30 2019-07-19 Minerva Biotechnologies Corp Proliferación de células que expresan MUC1
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
US20070224638A1 (en) * 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
WO2008070171A2 (en) * 2006-12-06 2008-06-12 Minerva Biotechnologies Corp. Method for identifying and manipulating cells
WO2009042814A1 (en) * 2007-09-25 2009-04-02 Minerva Biotechnologies Corp. Early diagnosis and treatment of drug resistance in muc1-positive cancer
WO2010042562A2 (en) * 2008-10-06 2010-04-15 Minerva Biotechnologies Corporation Muc1* antibodies
EP4201421A1 (en) 2008-10-09 2023-06-28 Minerva Biotechnologies Corporation Method for inducing pluripotency in cells
MY157524A (en) * 2009-06-11 2016-06-15 Minerva Biotechnologies Corp Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a muc1 or muc1* ligand
EP3065105B1 (en) * 2009-06-12 2020-04-29 Nikon Corporation Technique for determining the state of a cell aggregation, image processing program and image processing device using the technique, and method for producing a cell aggregation
EP2463379A1 (en) * 2009-07-31 2012-06-13 Nikon Corporation Technique for determining maturity of cell mass, and image processing program and image processing device which use the technique, and method for producing cell mass
US8450090B2 (en) 2009-10-06 2013-05-28 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for promoting fatty acid production in plants
JP5066615B2 (ja) 2011-01-31 2012-11-07 株式会社日立製作所 フェニルボロン酸基と特異的に結合するオリゴペプチド配列
AU2012326137B2 (en) 2011-10-17 2018-11-29 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
JP2016514954A (ja) * 2013-03-08 2016-05-26 クロンズ ホールディングズ カンパニー リミテッドＣｕｒｏｎｚ Ｈｏｌｄｉｎｇｓ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 神経再生ペプチドおよびその使用
MX2016009954A (es) 2014-01-29 2017-02-23 Dana Farber Cancer Inst Inc Anticuerpos contra el dominio extracelular de muc1-c (muc1-c/ecd).
CN104297442B (zh) * 2014-11-03 2016-08-17 天津中医药大学 内源性小分子物质在快速检测早期心脏毒性方面的应用
US11123366B1 (en) * 2014-12-15 2021-09-21 Children's Hospital Of Orange County Methods, materials, and systems for treating injuries to the central nervous system using light emitting nanoparticles
CN107660213B (zh) 2015-02-10 2023-01-13 米纳瓦生物技术公司 人源化抗MUCl＊抗体
US10617773B2 (en) 2016-08-05 2020-04-14 Dana-Farber Cancer Institute, Inc. Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
SG11201903254PA (en) * 2016-10-17 2019-05-30 Univ Keio Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells
CN111875712A (zh) * 2020-07-31 2020-11-03 广东昭泰体内生物医药科技有限公司 一种增强型靶向muc1的嵌合抗原受体及其应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1997A (en) 1841-03-03 Improvement in the mode of rendering fabrics water-proof
US603173A (en) 1898-04-26 Motor
US1504A (en) 1840-03-03 Mode osi constructing- bedsteads
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5108933A (en) * 1988-09-16 1992-04-28 Immunicon Corporation Manipulation of colloids for facilitating magnetic separations
JPH02273195A (ja) * 1988-11-17 1990-11-07 Univ Melbourne ヒト多型性上皮ムチンと反応するモノクローナル抗体
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
FR2668064B1 (fr) 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
AU710504B2 (en) 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
FR2746016B1 (fr) * 1996-03-15 1998-04-17 Combinaisons d'enzymes pour la destruction de cellules proliferatives
US6177393B1 (en) * 1996-12-12 2001-01-23 The Procter & Gamble Company Process for making tabletted detergent compositions
CA2282683A1 (en) * 1997-02-18 1998-08-20 Canji, Inc. Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
EP1137938A4 (en) 1998-12-08 2003-03-19 Smithkline Beecham Corp METHODS FOR DETECTION OF HDPXU17 RECEPTOR AGONISTS AND ANTAGONISTS
AU3347900A (en) 1999-01-23 2000-08-07 Minerva Biotechnologies Corporation Interaction of colloid-immobilized species with species on non-colloidal structures
CA2361013A1 (en) 1999-01-25 2000-07-27 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
US6421389B1 (en) * 1999-07-16 2002-07-16 Time Domain Corporation Baseband signal converter for a wideband impulse radio receiver
ATE330598T1 (de) * 1999-11-12 2006-07-15 Univ Johns Hopkins Behandlung von krebs durch erhöhung des malonyl- coa-spiegels
JP2003533181A (ja) * 2000-02-01 2003-11-11 ジ・オースティン・リサーチ・インスティテュート ムチン−１誘導抗原および免疫療法におけるその使用
DE60140461D1 (de) * 2000-09-11 2009-12-24 Genzyme Corp Muc1 extrazelluläre domäne und zusammensetzungen für krebsbehandlung, und davon abgeleitete verfahren
AU2002248909A1 (en) 2000-11-15 2002-05-27 Minerva Biotechnologies Corporation Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition
EP1354196B1 (en) 2000-11-27 2010-09-15 Minerva Biotechnologies Corporation Diagnostics, drug screening and treatment for cancer
WO2002078598A2 (en) 2001-03-29 2002-10-10 Ramot University Authority For Applied Research & Industrial Development Ltd. Peptides and antibodies to muc 1 proteins
WO2003020279A2 (en) 2001-09-05 2003-03-13 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
JP2005501887A (ja) 2001-09-05 2005-01-20 ミナーヴァ・バイオテクノロジーズ・コーポレーション 癌の処置における組成物およびその使用
US6716627B2 (en) 2001-12-20 2004-04-06 Isis Pharmaceuticals, Inc. Antisense modulation of mucin 1, transmembrane expression
WO2003089451A2 (en) 2002-04-22 2003-10-30 Dyax Corporation Antibodies specific for mucin polypeptide
JP2006502110A (ja) 2002-07-03 2006-01-19 イミュノジェン・インコーポレーテッド 非放出Ｍｕｃ１およびＭｕｃ１６に対する抗体、およびその使用
JP2007531505A (ja) 2002-11-27 2007-11-08 ミネルバ バイオオテクノロジーズ コーポレーション 癌（ｍｕｃ１）の診断および治療のための技術および組成物
US8510225B2 (en) 2004-09-01 2013-08-13 Research In Motion Limited Split channel authenticity queries in multi-party dialog

Similar Documents

Publication Publication Date Title
JP2010106028A5 (zh)
JP2004534730A5 (zh)
CN109765378B (zh) 一种新的肝硬化或肝纤维化标志物
EP2414836B1 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
JP2008535494A5 (zh)
WO2006105642A1 (en) Biomarkers for the detection of lung cancer and uses thereof
JP2007533985A5 (zh)
Von Euler et al. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases
KR20080113368A (ko) 네트린-1 활성을 이용한 항암 화합물의 스크리닝
CN108496083A (zh) 用于检测包含组蛋白修饰和变体的核小体的方法
CN110402393A (zh) 疾病诊断的组合物
Kaltner et al. Prototype chicken galectins revisited: characterization of a third protein with distinctive hydrodynamic behaviour and expression pattern in organs of adult animals
EP2452948B1 (en) New tumor marker
JP2011503620A (ja) リン酸化脂肪酸シンターゼ及び癌
AU672808B2 (en) Method of determining metastatic potential of tumor cells
WO2016072464A1 (ja) デオキシハイプシン・シンターゼ遺伝子を指標として用いる動脈硬化及びがんの検出方法
CN108139404A (zh) 特异性地识别、结合活性结构的REIC/Dkk-3蛋白的抗体、以及使用该抗REIC/Dkk-3抗体的癌治疗的监测
JP6004369B2 (ja) 糖尿病合併症マーカーとなり得る新規ｒａｇｅリガンド
US20150377889A1 (en) Galectin-3 as a marker for prostate cancer
KR20070001913A (ko) 자궁경부 표본에서 암 바이오마커를 검출하기 위한 방법
TWI842716B (zh) 泌尿道上皮細胞癌生物標記及其應用
US8673309B2 (en) Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
JP2000131321A (ja) 膀胱癌患者の予後診断薬
WO2015026893A1 (en) Predictive biomarkers for metabolic syndrome
WO2011158863A1 (ja) タンパク質キナーゼの新規基質ペプチド